Skip to content
healthcare.dev

POTASSIUM CITRATE

NDC 31722-132, Potassium Citrate, tablet, extended release, from Camber Pharmaceuticals, Inc.

Product NDC
31722-132
Status
Listed
Labeler
Camber Pharmaceuticals, Inc
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214420
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CITRATE15 meq/1

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
31722-132-0131722013201100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-132-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ea933654-e8d2-4662-9a9a-4a6d79a9fb20
  • NADAC price for package 31722013201

    GET /v1/drugs/nadac/31722013201

Use it

Look up 31722-132 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.